$ANTX 3 SEC Filings

Filed On	Filing
27 Aug 2026	Form 3: Trenor Cameron C. Iii, Chief Medical Officer No securities owned
03 Feb 2026	Form 3: Williams Sarah Joanne, Principal Accounting Officer Holds 18,800 shares of Common Stock
05 Nov 2024	Form 3: Prior Stephen David, Chief Strategy Officer Holds 25,217 shares of Common Stock
12 Aug 2024	Form 3: Leonard Braden Michael, 10% owner Holds 4,249,432 shares of Common Stock
05 Oct 2022	Form 3: Eizen Joshua M, See Remarks No securities owned
09 May 2022	Form 3: FitzPatrick Margaret M, Director No securities owned
24 Mar 2022	Form 3: Krause Kevin Michael, Chief Strategy Officer
24 Mar 2022	Form 3: Spigelman Melvin K, Director
24 Mar 2022	Form 3: Martin Patricia A., Director
24 Mar 2022	Form 3: Zakrzewski Joseph S, Director Holds 505,880 shares of Common Stock
24 Mar 2022	Form 3: Eckburg Paul, Chief Medical Officer Holds 18,289 shares of Common
24 Mar 2022	Form 3: Aziz Kabeer, Director
24 Mar 2022	Form 3: Nazak Michael Adrian, Chief Accounting Officer
24 Mar 2022	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 4 others
24 Mar 2022	Form 3: Marks Gilbert Lynn, Director Holds 22,830 shares of Common Stock
24 Mar 2022	Form 3: Readnour Robin Shane, Director
24 Mar 2022	Form 3: Day Lucy, Chief Financial Officer
24 Mar 2022	Form 3: Easom Eric, Director Holds 1,099,997 shares of Common Stock
24 Mar 2022	Form 3: Chanda Sanjay, Chief Development Officer
24 Mar 2022	Form 3: Adjuvant Global Health Technology Fund, L.p., 10% owner and 1 other

Comments